Assessment of new technologies: Surrogate endpoints versus outcomes, and the cost of health care
β Scribed by George A. Beller
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 29 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1071-3581
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In this paper we examine whether the current method of valuing time within economic appraisals is appropriate. The cost to society of time taken to use health care may differ from the private opportunity cost of such time. However, demand for health care may be affected by the private opportunity ti
High deductible health plans (HDHPs) have become an increasingly common form of benefit design used by employers to manage health-care costs. Numerous studies have evaluated the uptake and impact of HDHPs on health-care utilization. Most studies have employed the standard difference-in-differences (
## Abstract Markov models have traditionally been used to evaluate the costβeffectiveness of competing health care technologies that require the description of patient pathways over extended time horizons. Discrete event simulation (DES) is a more flexible, but more complicated decision modelling t